Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pediatric Perfusion Market, by End Use
1.4.2 North America Pediatric Perfusion Market, by Product
1.4.3 North America Pediatric Perfusion Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Pediatric Perfusion Market
Chapter 5. North America Pediatric Perfusion Market by End-use
5.1 North America Hospitals Market by Country
5.2 North America Cardiac Centers Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Pediatric Perfusion Market by Product
6.1 North America Pediatric Oxygenators Market by Country
6.2 North America Pediatric Cannulae Market by Country
6.3 North America Pediatric Blood Pumps Market by Country
6.4 North America Pediatric Arterial Filters Market by Country
6.5 North America Monitoring Systems Market by Country
6.6 North America Others Market by Country
Chapter 7. North America Pediatric Perfusion Market by Country
7.1 US Pediatric Perfusion Market
7.1.1 US Pediatric Perfusion Market by End-use
7.1.2 US Pediatric Perfusion Market by Product
7.2 Canada Pediatric Perfusion Market
7.2.1 Canada Pediatric Perfusion Market by End-use
7.2.2 Canada Pediatric Perfusion Market by Product
7.3 Mexico Pediatric Perfusion Market
7.3.1 Mexico Pediatric Perfusion Market by End-use
7.3.2 Mexico Pediatric Perfusion Market by Product
7.4 Rest of North America Pediatric Perfusion Market
7.4.1 Rest of North America Pediatric Perfusion Market by End-use
7.4.2 Rest of North America Pediatric Perfusion Market by Product
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 LivaNova PLC
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Terumo Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 BL Lifesciences (BL group of family companies)
8.4.1 Company Overview
8.4.2 SWOT Analysis
8.5 Cardinal Health, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 SWOT Analysis
8.6 EUROSETS S.R.L. (GVM Care Research)
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Getinge AB
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Koninklijke Philips N.V.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Product Launches and Product Expansions:
8.8.6 SWOT Analysis
8.9 Nonin Medical, Inc.
8.9.1 Company Overview
8.10. GE HealthCare Technologies, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
Unique Offerings 